Cornerstone Therapeutics Inc (NASDAQ:CRTX)

Add to Watch List

Set Alert

8.46 Data as of 2:38pm ET	+0.05 / +0.59% Today’s Change	3.10 Today\|\|\|52-Week Range 9.13	+78.86% Year-to-Date

8.46

Data as of 2:38pm ET

+0.05 / +0.59%

Today’s Change

3.10

Today|||52-Week Range

9.13

+78.86%

Year-to-Date

SECTOR

Health Technology

INDUSTRY

Biotechnology

MARKET CAP

$225.4M

Company Description

Cornerstone Therapeutics, Inc. is a specialty pharmaceutical company, which is focused on commercializing products for the hospital, niche respiratory and related specialty markets. The company's strategy is to pursue acquisition or licensing transactions to acquire the rights to patent-protected, branded respiratory or related pharmaceutical products or late stage product candidates, to implement life cycle management, newly acquired products and product candidates that are currently in development. The company was founded on October 31, 2008 and is headquartered in Cary, NC.

Contact Information

Cornerstone Therapeutics, Inc.

1255 Crescent Green Drive

Cary North Carolina 27518-8128

P:(919) 678-6611

Investor Relations:
(919) 678-6520

www.crtx.com

Employees

Shareholders

Other institutional	9.71%
Individual stakeholders	65.00%
Mutual fund holders	3.17%

Top Executives

Craig A. Collard	Chairman & Chief Executive Officer
Kenneth R. McBean	President
Alastair Stuart McEwan	Chief Financial Officer & Treasurer
Alan T. Roberts	Vice President-Scientific Affairs
Andrew Kenneth William Powell	Secretary, Executive VP & General Counsel

To view my watchlist

Not a member yet?

jobs by

Search for jobs

Search All Jobs from Across the Web

About CNNMoney
Content
Magazines
Site Tools
Stay Connected
- My Account
- Mobile Site & Apps
- Facebook
- Twitter
- LinkedIn
- YouTube
- RSS Feeds
- Newsletters
- Tumblr
- Google+

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2013 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones Indexes^SM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones Indexes^SM © 2013 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2013. All rights reserved. Most stock quote data provided by BATS.